rs201570574
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001465.6(FYB1):c.945G>T(p.Lys315Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000479 in 1,613,900 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.00026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00050 ( 1 hom. )
Consequence
FYB1
NM_001465.6 missense
NM_001465.6 missense
Scores
4
14
Clinical Significance
Conservation
PhyloP100: 0.632
Genes affected
FYB1 (HGNC:4036): (FYN binding protein 1) The protein encoded by this gene is an adapter for the FYN protein and LCP2 signaling cascades in T-cells. The encoded protein is involved in platelet activation and controls the expression of interleukin-2. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.087768525).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FYB1 | NM_001465.6 | c.945G>T | p.Lys315Asn | missense_variant | 2/19 | ENST00000512982.4 | NP_001456.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FYB1 | ENST00000512982.4 | c.945G>T | p.Lys315Asn | missense_variant | 2/19 | 2 | NM_001465.6 | ENSP00000425845.3 | ||
FYB1 | ENST00000351578.12 | c.945G>T | p.Lys315Asn | missense_variant | 2/18 | 1 | ENSP00000316460.7 | |||
FYB1 | ENST00000515010.5 | c.945G>T | p.Lys315Asn | missense_variant | 1/17 | 1 | ENSP00000426346.1 | |||
FYB1 | ENST00000646045.2 | c.975G>T | p.Lys325Asn | missense_variant | 2/19 | ENSP00000493623.1 |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 152198Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
40
AN:
152198
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000221 AC: 55AN: 249222Hom.: 0 AF XY: 0.000244 AC XY: 33AN XY: 135198
GnomAD3 exomes
AF:
AC:
55
AN:
249222
Hom.:
AF XY:
AC XY:
33
AN XY:
135198
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000501 AC: 733AN: 1461702Hom.: 1 Cov.: 31 AF XY: 0.000499 AC XY: 363AN XY: 727132
GnomAD4 exome
AF:
AC:
733
AN:
1461702
Hom.:
Cov.:
31
AF XY:
AC XY:
363
AN XY:
727132
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000263 AC: 40AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74348
GnomAD4 genome
AF:
AC:
40
AN:
152198
Hom.:
Cov.:
32
AF XY:
AC XY:
16
AN XY:
74348
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
5
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
4
ExAC
AF:
AC:
29
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 05, 2023 | The c.945G>T (p.K315N) alteration is located in exon 1 (coding exon 1) of the FYB gene. This alteration results from a G to T substitution at nucleotide position 945, causing the lysine (K) at amino acid position 315 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Apr 06, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.;.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
.;.;T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.;.;N;N
REVEL
Benign
Sift
Uncertain
D;.;.;D;D
Sift4G
Benign
T;.;T;T;T
Polyphen
D;.;.;D;.
Vest4
MutPred
Loss of methylation at K315 (P = 0.0183);.;.;Loss of methylation at K315 (P = 0.0183);Loss of methylation at K315 (P = 0.0183);
MVP
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at